Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or ...

One firm wants to allow its employees to access their files and applications from anywhere. The IT team at a second company is focused on its disaster recovery strategy, and a third organization has ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with type 1 diabetes. When you purchase through links on our site, we may earn ...

Most people know there are two types of diabetes—type 1 and type 2. Knowing which one you have matters quite a lot for how you treat them. But what you may not know about is a lesser-known variation ...

One very successful drug for type 2 diabetes management is semaglutide. It works as a glucagon-like peptide 1 (GLP-1) agonist, stimulating insulin release and reducing glucagon secretion, which leads ...